Introduction {#sec1}
============

Stereo- or regiocontrolled selective construction of unsaturated molecular scaffolds through sequential multiple carbon--carbon (C--C) bond formation remains one of the major challenges in organic chemistry. In particular, in cascade reactions, transition-metal-catalyzed cyclizations of allenes provide efficient and atom-economical routes to polyunsaturated molecules.^[@ref1]^ Polyenes and oligoenes occur as structural elements in pharmaceutically active compounds and important natural products such as Vitamin A, Lycopene, β-carotene, Lutein, lissoclinolide, naturally occurring \[3\]dendralenes, etc. ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).^[@ref2]^ The synthesis of such nonaromatic cross-conjugated \[3\]dendralenes have recently attracted considerable interest.^[@ref3],[@ref4]^

![Examples of Polyene Compounds](jo0c00186_0002){#sch1}

In recent years, acyclic cross-conjugated polyenes (dendralenes) have been used in diene transmissive Diels--Alder (DTDA) sequences for rapid generation of complex scaffolds bearing multiple stereogenic centers ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).^[@ref5]^ Due to regioselective functionalization of the multiple olefinic sites, other applications of dendralenes are found in the synthesis of ivyane family compounds,^[@ref6]^ vinylogous Nazarov reactions,^[@ref7]^ organocatalytic domino cyclizations,^[@ref8]^ oxidative reactions,^[@cit9a]^ and metathesis of \[3\]dendralene--Fe(CO)~3~ complexes.^[@cit9b]^ However, synthetic methods for the preparation of higher cross-conjugated polyenes are quite limited as one-step reactions. In this respect, Hopf, Sherburn, Shimizu and their co-workers reported on acyclic cross conjugated polyenes.^[@cit3b],[@ref10]−[@ref12]^ Recently, the Lipshutz group reported a tandem borylation/Suzuki--Miyaura reaction for the synthesis of cross-conjugated polyenes such as \[4\]- and \[5\]dendralene ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}A).^[@ref13]^

![Examples of Cross-Conjugated Polyenes Applications](jo0c00186_0003){#sch2}

![Example of Polyene Synthesis and Proposal for this Work](jo0c00186_0004){#sch3}

In the past decade, our research group has focused on Pd(II)-catalyzed oxidative carbocyclization reactions of allenes^[@cit1h]^ and we reported the synthesis of various types of \[3\]dendralenes via C--C bond formation.^[@cit3d]^ Compared to intramolecular reactions of allenes, intermolecular couplings of allenes are more challenging and would provide an array of novel conjugated structures. To the best of our knowledge, intermolecular cascade reactions between allenes with C--C bond formation for the synthesis of cross-conjugated polyenes have not yet been reported in a one-pot reaction. We therefore decided to study palladium(II)-catalyzed oxidative coupling and carbocyclization reactions of enallenes with allenynes for the synthesis of polyenes ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"} B). These cross-conjugated polyenes will have the (*Z*)-configuration at the middle double bond. The synthesis of the unsubstituted (*E*)-isomer of the corresponding polyene has been reported by Paddon-Row and Sherburn (lower box, [Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}B).^[@cit9b]^

In this report, palladium-catalyzed intermolecular carbocyclization cascade reactions provide a wide variety of interesting polyene products in high yield and with excellent regio- and stereoselectivity ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}, B).

Results and Discussion {#sec2}
======================

In our initial investigation, allenyne **1a** and enallene **2a** were chosen as the substrates for this challenging transformation ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}).

![Cascade Reaction\
**Method A**: **2a** (2 equiv), Pd(OAc)~2~ (5 mol %), BQ (2 equiv), Na~2~CO~3~ (20 mol %), CH~3~CN, 80 °C, 24 h. **Method B**: Pd(OAc)~2~ (5 mol %), BQ (20 mol %), Co(salophen) (5 mol %), Na~2~CO~3~ (20 mol %), CH~3~CN, 80 °C, O~2~ balloon, 24 h.](jo0c00186_0005){#sch4}

Preparation of Starting Materials {#sec2.1}
---------------------------------

All allenynes **1** were prepared from propargyl malonate and the corresponding bromoallenes ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"} and [Experimental Section](#sec4){ref-type="other"}). The eneallenes **2** were synthesized from propargyl alcohol derivatives and subsequent 1,3-rearrangement or iron-catalyzed S~N~2′ Grignard reaction (see [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.joc.0c00186/suppl_file/jo0c00186_si_001.pdf)).

![Preparation of Allenynes](jo0c00186_0006){#sch5}

In preliminary experiments, we observed that treatment of **1a** and 1.1 equiv of **2a** with 5 mol % of Pd(OAc)~2~ and 1.1 equiv of benzoquinone (BQ) in DCE at 80 °C gave a 64% NMR yield of the regio- and stereodefined dendralene derivative **3a** together with 6% of cycloisomerization product **5** ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 1).^[@ref14]^ With these inspiring results in hand, we set out to determine the role of the solvent and the Pd(II) catalyst. In a screening of various solvents in the presence of Pd(OAc)~2~ catalyst ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 1--8), CH~3~CN was found to be the best solvent, which delivered the product **3a** in 75% yield without formation of side product **5** (entry 8). Furthermore, palladium catalyst screening showed that Pd(TFA)~2~, Pd(PPh~3~)~2~Cl~2~, and Pd(PhCN)~2~Cl~2~ were not suitable for the reaction and in these cases the allenyne **1a** and enallene **2a** were recovered ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 9--11). However, Pd(acac)~2~ catalyzed the reaction efficiently to give the product **3a** in 60% yield. ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 12). In further optimizations, treatment of **1a** and 1.5 equiv of **2a** with 5 mol % of Pd(OAc)~2~, and 1.5 equiv of BQ afforded **3a** in 80% yield ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 13). Increasing **1a** and BQ to 2.0 equiv each with 1 mol % of Pd(OAc)~2~ improved the yield of **3a** to 83% ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 14). The yield of **3a** further increased with the addition 0.2 equiv of Na~2~CO~3~ ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 15). With an increased reaction time, we found that treatment of **1a** and 2.0 equiv of **2a** with 5 mol % of Pd(OAc)~2~, and 2.0 equiv of BQ in CH~3~CN at 80 °C for 24 h afforded **3a** in 94% yield (Method A) ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 16). Additives such as Et~3~N or AcOH did not improve the yield of **3a** ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 17--18).

###### Optimizatiion of the Reaction[a](#t1fn1){ref-type="table-fn"}

![](jo0c00186_0009){#GRAPHIC-d7e512-autogenerated}

                                                                                                                                             Yield (%)[b](#t1fn2){ref-type="table-fn"}        
  ----------------------------------------------------------------------------------------------------------- -------------------- --------- ------------------------------------------- ---- -------
  1                                                                                                           Pd(OAc)~2~           DCE       64                                          6    --
  2                                                                                                           Pd(OAc)~2~           Dioxane   51                                          6    --
  3                                                                                                           Pd(OAc)~2~           DMSO      55                                          --   --
  4[c](#t1fn3){ref-type="table-fn"}                                                                           Pd(OAc)~2~           THF       43                                          --   --
  5[c](#t1fn3){ref-type="table-fn"}                                                                           Pd(OAc)~2~           MeOH      50                                          4    --
  6[c](#t1fn3){ref-type="table-fn"}                                                                           Pd(OAc)~2~           Acetone   33                                          --   --
  7                                                                                                           Pd(OAc)~2~           Toluene   65                                          7    --
  8                                                                                                           Pd(OAc)~2~           MeCN      75                                          --   --
  9                                                                                                           Pd(TFA)~2~           MeCN      --                                          --   94/91
  10                                                                                                          Pd(PPh~3~)~2~Cl~2~   MeCN      --                                          --   70/71
  11                                                                                                          Pd(MeCN)~2~Cl~2~     MeCN      --                                          --   71/47
  12                                                                                                          Pd(acac)~2~          MeCN      60                                          6    --
  13[g](#t1fn7){ref-type="table-fn"}                                                                          Pd(OAc)~2~           MeCN      80                                          --   --
  14[d](#t1fn4){ref-type="table-fn"}^,^[f](#t1fn6){ref-type="table-fn"}                                       Pd(OAc)~2~           MeCN      83                                          --   --
  15[d](#t1fn4){ref-type="table-fn"}^,^[e](#t1fn5){ref-type="table-fn"}                                       Pd(OAc)~2~           MeCN      88                                          --   --
  16[d](#t1fn4){ref-type="table-fn"}^,^[e](#t1fn5){ref-type="table-fn"}^,^[h](#t1fn8){ref-type="table-fn"}    Pd(OAc)~2~           MeCN      94                                          --   --
  17[d](#t1fn4){ref-type="table-fn"}^,^[h](#t1fn8){ref-type="table-fn"}^,^[i](#t1fn9){ref-type="table-fn"}    Pd(OAc)~2~           MeCN      91                                          --   --
  18[d](#t1fn4){ref-type="table-fn"}^,^[h](#t1fn8){ref-type="table-fn"}^,^[j](#t1fn10){ref-type="table-fn"}   Pd(OAc)~2~           MeCN      90                                          --   --

The reaction was conducted in the indicated solvent (1 mL) at 80 °C using **1a** (0.1 mmol), allene-ene **2a** (0.11 mmol), and BQ (1.1 equiv) in the presence of palladium catalyst (5 mol %).

Yield determined by ^1^H NMR analysis using anisole as the internal standard.

The reaction was run at 60 °C.

**2a** (2.0 equiv) and 2.0 equiv of BQ was used.

0.2 equiv of Na~2~CO~3~ was used.

1 mol % Pd(OAc)~2~ was used.

**2a** (1.5 equiv) and 1.5 equiv of BQ was used.

Reaction time 24 h.

Et~3~N (20 mol %).

AcOH (20 mol %).

To demonstrate the necessity of the olefin group in the enallene **2a**,^[@ref15]^ comparative experiments with allenes lacking the pending olefin were carried out. Without the pending olefin, these reactions failed to give any cross-conjugated polyene product **3** with Method A in CH~3~CN ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}). Thus, when **4a** and **4b** were allowed to react with **1a**, no detectable amounts of **3** were formed. These results are in accordance with previous results that the olefin group of **2a** is an indispensable assisting/directing group for activation of the allene.^[@ref15]^

![Comparative Experiment](jo0c00186_0007){#sch6}

In further studies, we investigated Pd(II)-catalyzed aerobic oxidative coupling--carbocyclization reactions between allenyne **1a** and enallene **2a** for the synthesis of **3a** ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}, Method B). We have previously developed various biomimetic methods for palladium-catalyzed aerobic oxidation of unsaturated substrates.^[@ref16]^ The employment of an aerobic biomimetic oxidation system is an environmentally benign process associated with high atom economy.^[@ref17]^ A key feature of [Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}, Method B is the multistep electron transfer occurring, which enables a mild aerobic oxidation. This multistep electron transfer system involves three redox pairs: Pd^II^/Pd^0^, (BQ)/HQ, and Co(salophen)^ox^/Co(salophen). The BQ and Co(salophen) are used as electron transfer mediators (ETMs), and molecular oxygen is applied as the oxidant. We found that reaction of **1a** with **2a** in the presence of catalytic amounts of Pd(OAc)~2~ (5 mol %), BQ (20 mol %), and Co(salophen) (5 mol %) in CH~3~CN at 80 °C under molecular oxygen (1 atm) for 24 h afforded **3a** in 85% yield (Method B). Under optimized reaction conditions Methods A and B, we investigated the scope of the reaction by using different allenyne substrates ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, **1a**--**1j**).

###### Scope of Substrate **1**[a](#t2fn1){ref-type="table-fn"}

![](jo0c00186_0010){#GRAPHIC-d7e1062-autogenerated}

![](jo0c00186_0011){#gr8}

Isolated yield after column chromatography **Method A**: **2a** (2 equiv), Pd(OAc)~2~ (5 mol %), BQ (2 equiv), Na~2~CO~3~ (20 mol %), CH~3~CN, 80 °C, 24 h. **Method B**: Pd(OAc)~2~ (5 mol %), BQ (20 mol %), Co(salophen) (5 mol %), Na~2~CO~3~ (20 mol %), CH~3~CN, 80 °C, O~2~ balloon, 24 h.

Under standard nonaerobic conditions (Method A), with methyl groups at the terminal position of the allene moiety of the allenenyne or when these methyl groups were changed to cyclohexylidene or one of them to *t*-Bu, the reaction with **2a** gave the corresponding cross-conjugated polyene ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, **3a**--**3d**) in good yields (82--90%). The use of either stoichiometric amounts of BQ (Method A) or catalytic amounts of BQ under aerobic conditions (Method B) afforded similar results, as shown in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"} from the examples **3a** and **3d.** It is worth noting that the reaction of allenyne substrates **1e**--**1j** ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}) having two methyl ethers, a 1,3 dioxane, or two benzyl ethers in place of the two carboalkoxy groups, along with cyclohexylidene or tertiary butyl on the allene moiety, afforded the corresponding polyene derivatives ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, **3e**--**3j**) selectively in good yields (70--83%), except for **1i**, which afforded **3i** in 34% yield. These results show that the malonate group of the tether is not necessary for a successful transformation.

To expand the scope of the method, we tested differently substituted enallenes **2** for the coupling--carbocyclization cascade reaction using allenyne **1a** as the cosubstrate. Under standard conditions (Method A), a number of functionalized enallenes **2** served as excellent candidates for formation of cross-conjugated polyenes in good yields. When allyl-substituted 2,3-dienoate (**2k**) was employed, the reaction gave the desired product **3k** in 85% yield. Variation of the methyl groups on the allene moiety of **2**, e.g. deuterated methyls (**2l**), cyclohexylidene group (**2m**), cyclopentylidene group (**2n**), or one methyl presence (**2o**), in the reaction with **1a** provided the corresponding cross-conjugated polyenes in good yields ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, **3l**--**3o**). Moreover, substrates **2p**--**2s** with methyl, ethyl, or phenyl substitution on the olefin moiety afforded **3p**--**3s** ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}) in moderate to good yields (57--80%). Reaction of substituted enallenes **2t**--**2v** with **1a** afforded the desired products **3t**--**3v** in 60--80% yield ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). As shown in [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, the reaction also works under aerobic conditions with catalytic amounts of BQ together with Co(salophen) in catalytic amounts (Method B). Thus, reaction of enallenes **2k, 2m**--**2n** with **1a** using molecular oxygen as the oxidant afforded products **3k**, **3m**--**3n** in 77--85% yield ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}).

###### Scope of Enallene Substrates **2**[a](#t3fn1){ref-type="table-fn"}

![](jo0c00186_0012){#GRAPHIC-d7e1285-autogenerated}

![](jo0c00186_0013){#gr9}

Isolated yield after column chromatography. **Method A**: **2a** (2 equiv), Pd(OAc)~2~ (5 mol %), BQ (2 equiv), Na~2~CO~3~ (20 mol %), CH~3~CN, 80 °C, 24 h. **Method B**: Pd(OAc)~2~ (5 mol %), BQ (20 mol %), Co(salophen) (5 mol %), Na~2~CO~3~ (20 mol %), CH~3~CN, 80 °C, O~2~ balloon, 24 h.

To gain further insight into the reaction mechanism, the deuterium kinetic isotope effects (KIE) were studied ([eqs [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"}--[3](#eq1){ref-type="disp-formula"}). An intermolecular competition experiment was conducted at 75 °C using a 1:1 mixture of **2a** and **2a-***d*~6~ ([eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"}). The products ratio **3a** and **3a-***d*~5~ was measured as 1.8:1, from which the competitive KIE was determined to be *k*~H~/*k*~D~ = 3.5 (see [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.joc.0c00186/suppl_file/jo0c00186_si_001.pdf)). Furthermore, parallel kinetic experiments afforded a KIE (*k*~H~/*k*~D~ from initial rate) value of 3.4 ([eqs [2](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"} and [3](#eq1){ref-type="disp-formula"}) which indicates the initial allenylic C(sp^3^)--H bond cleavage is involved in the rate-determining step in the reaction. The large competitive KIE (*k*~H~/*k*~D~ = 3.5) in C--H bond cleavage requires that this step is the first irreversible step.

Based on the mechanistic studies including the KIE measurements ([eqs [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"}--[3](#eq1){ref-type="disp-formula"}) and our previous work,^[@ref18]^ we propose the mechanism as shown in [Scheme [7](#sch7){ref-type="scheme"}](#sch7){ref-type="scheme"}. The large deuterium isotope effect found for the C--H bond cleavage of the enallene **2a** indicates that the enallene is the compound first activated and not the allenyne.^[@ref19]^ Initial reaction of Pd(OAc)~2~ with enallene **2** would give dienyl--Pd^II^ complex *Int***-2** via allenic C--H bond cleavage of chelated π-complex *Int***-1** ([Scheme [7](#sch7){ref-type="scheme"}](#sch7){ref-type="scheme"}). This activation of the allene is triggered by the coordination of the assisting olefin.^[@ref15]^ Vinylpalladium intermediate *Int***-2** would then undergo an insertion of the vinylpalladium bond into the alkyne of allenyne **1**, which leads to *Int***-3**. Subsequent intramolecular insertion of the vinylpalladium bond of *Int***-3** into the allene would lead to (π-allyl)-palladium intermediate *Int***-4**. Subsequent β-hydride elimination via C(*sp*^*3*^)--H bond cleavage would provide the cross-conjugated polyene **3** and release Pd^0^ for the next cycle.

![Proposed Mechanism for the Formation of **3**](jo0c00186_0008){#sch7}

![](jo0c00186_0001){#e1}

Conclusion {#sec3}
==========

We have developed an efficient one-pot Pd^II^-catalyzed oxidative coupling--carbocyclization cascade reaction for the synthesis of cross-conjugated polyene via intermolecular C--C bond formation and subsequent carbocyclization. This transformation allows highly regio- and stereoselective formation of cross-conjugated polyenes using enallene and allenyne under aerobic conditions with environmentally friendly O~2~ as the terminal oxidant. These important cross-conjugated polyenes, which are readily obtained in a one-pot cascade reaction in the present work, are difficult to prepare by other methods. Further studies on the scope of natural product synthesis and other synthetic application of this new cascade reaction are currently underway in our laboratory.

Experimental Section {#sec4}
====================

General Information {#sec4.1}
-------------------

For the synthesis of complex molecules, unless otherwise noted, all reagents were used as received from the commercial suppliers. Pd(OAc)~2~ was obtained from Pressure Chemicals and used without further purification. Alkynes were commercially available from Sigma-Aldrich or Acros. The palladium-catalyzed cascade reactions could be performed without any efforts to exclude moisture. DCE was distilled using CaH~2~, Dry THF and toluene, were obtained froma VAC Solvent Purifier. The other dry solvents were purchased from Sigma-Aldrich. Reactions were monitored using thin-layer chromatography (TLC) (SiO~2~). TLC plates were visualized with UV light (254 nm) or KMnO~4~ stain. Flash chromatography was carried out with 60 Å (particle size 35--70 μm) normal flash silica gel. NMR spectra were recorded at 400 MHz (^1^H) or 500 MHz (^1^H) and at 100 MHz (^13^C) or 125 MHz (^13^C), respectively. Chemical shifts (δ) are reported in ppm, using the residual solvent peak in CDCl~3~ (H = 7.26 and C = 77.0 ppm) as the internal standard, and coupling constants (*J*) are given in Hz. HRMS data were recorded using ESI-TOF techniques.

Allenynes **1a**([@ref20]) and **1c**([@ref21]) were prepared as described in literature. Allenynes **1b** and **1d** were prepared from propargylmalonate and the corresponding bromoallene in a similar manner.^[@ref20]^ All allene derivatives **2a**, **2k**--**2v**, and **4a**--**4b** were prepared according to a previously described procedures.^[@cit3d],[@ref15],[@cit18c],[@ref22]^

Representative Procedure for the Synthesis of **1b** and **1d**: Synthesis of **1b** {#sec4.2}
------------------------------------------------------------------------------------

To a suspension of NaH (60% in mineral oil, 0.456 g, 11.4 mmol) in anhydrous THF (60 mL) was added a solution of diethyl propargylmalonate (2.0 g, 8.83 mmol) in anhydrous THF (5 mL) at 0 °C. After the addition, the mixture was stirred for another 20 min at room temperature Then a solution of bromoallene (2.6 g, 17.6 mmol) in anhydrous THF (5 mL) was added at room temperature and the resulting mixture was refluxed for 20 h. After the reaction was complete as monitored by TLC, it was cooled to room temperature. Most of the solvent was removed under vacuum, and then the reaction mixture was diluted with 50 mL of Et~2~O and quenched with 10 mL of water. The organic layer was separated, and the aqueous layer was extracted with diethyl ether (2 × 20 mL). The combined organic layers were dried over Na~2~SO~4~. Evaporation and column chromatography on silica gel (pentane/ethyl acetate = 30/1) afforded **1b** (0.71 g, 31%).

Characterization of Allenynes **1b** and **1d** {#sec4.3}
-----------------------------------------------

### Diethyl-2-(3-methyl-2λ^5^-buta-1,2-dien-1-yl)-2-(prop-2-yn-1-yl)malonate (**1b**) {#sec4.3.1}

^1^H NMR (400 MHz, CDCl~3~) δ = 4.94 (sept, *J* = 2.9 Hz, 1H), 4.25--4.15 (m, 4H), 2.86 (d, *J* = 2.7 Hz, 2H), 1.95 (t, *J* = 2.7 Hz, 1H), 1.71 (d, *J* = 2.9 Hz, 6H), 1.25 (t, *J* = 7.1 Hz, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 201.7, 169.2, 100.5, 87.7, 79.6, 70.4, 61.7, 57.5, 24.3, 19.9, 13.9; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~15~H~20~O~4~Na, 287.1254; found, 287.1263. Isolated yield: 31% (0.71 g), as a liquid. Column chromatography on silica gel (pentane/ethyl acetate = 30/1).

In the same manner **1d** was obtained from 1-bromo-3,4,4-trimethyl-1,2-pentadiene.

### Dimethyl-2-(prop-2-yn-1-yl)-2-(3,4,4-trimethyl-2λ^5^-penta-1,2-dien-1-yl)malonate (**1d**) {#sec4.3.2}

^1^H NMR (400 MHz, CDCl~3~) δ = 5.64 (q, *J* = 2.9 Hz, 1H), 3.74 (d, *J* = 9.5 Hz, 6H), 2.87 (d, *J* = 2.7 Hz, 2H), 1.97 (t, *J* = 2.7 Hz, 1H), 1.71 (d, *J* = 2.8 Hz, 3H), 1.02 (s, 9H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 200.0, 169.6, 114.2, 89.2, 79.5, 70.7, 57.7, 52.8, 52.7, 33.7, 28.8, 24.6, 14.5; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~16~H~22~O~4~Na, 301.1410; found, 301.1421. Isolated yield: 32% (0.79 g), as a liquid. Column chromatography on silica gel (pentane/ethyl acetate = 30/1).

Representative Procedure for the Synthesis of **1ax**, **1cx**, and **1dx**: Synthesis of **1ax** {#sec4.4}
-------------------------------------------------------------------------------------------------

To a suspension of LiAlH~4~ (171 mg, 4.5 mmol) in anhydrous Et~2~O (15 mL) was added a solution of **1a** (0.34 g, 1.5 mmol) in anhydrous Et~2~O (10 mL) at 0 °C. After the addition, the mixture was stirred for another 2 h at rt and carefully quenched with H~2~O (5 mL). The resulting mixture was extracted with diethyl ether (2 × 30 mL). The combined organic layers were washed with H~2~O (20 mL) and dried (Na~2~SO~4~), and the solvent was removed under reduced pressure. The crude product was purified by column chromatography (silica gel, pentane/ethyl acetate = 1:3) to yield **1ax** (203 mg, 79% yield) as a white solid.

Compounds **1cx** and **1dx** were prepared from **1c** and **1d**, respectively, in the same manner.

Characterization of Products **1ax**, **1cx**, and **1dx** {#sec4.5}
----------------------------------------------------------

### 2-(3-Methyl-2λ^5^-buta-1,2-dien-1-yl)-2-(prop-2-yn-1-yl)propane-1,3-diol (**1ax**) {#sec4.5.1}

^1^H NMR (400 MHz, CDCl~3~) δ = 4.94 (sept, *J* = 2.9 Hz, 1H), 3.69 (s, 4H), 2.40 (d, *J* = 2.7 Hz, 2H), 2.04 (bs, 2H), 2.02 (d, *J* = 2.7 Hz, 1H), 1.71 (d, *J* = 3.0 Hz, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 201.7, 98.3, 90.0, 81.1, 70.6, 67.4, 44.5, 22.9, 20.6; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~11~H~16~O~2~Na, 203.1043; found, 203.1049. Isolated yield: 79% (203 mg), as a semi-solid. Column chromatography (silica gel, pentane/ethyl acetate = 1:3).

### 2-(2-Cyclohexylidene-2λ^5^-vinyl)-2-(prop-2-yn-1-yl)propane-1,3-diol (**1cx**) {#sec4.5.2}

^1^H NMR (400 MHz, CDCl~3~) δ = 4.94 (quint, *J* = 2.9 Hz, 1H), 3.67 (d, *J* = 1.0 Hz, 4H), 2.39 (d, *J* = 2.7 Hz, 2H), 2.39 (bs, 2H), 2.16--2.06 (m, 4H), 2.00 (t, *J* = 2.7 Hz, 1H), 1.42--1.68 (m, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 198.3, 105.5, 89.8, 81.1, 70.6, 67.2, 44.4, 31.6, 27.3, 25.9, 22.9; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~14~H~20~O~2~Na, 243.1356; found, 243.1362. Isolated yield: 81% (268 mg), as a semi-solid. Column chromatography (silica gel, pentane/ethyl acetate = 1:2.5).

### 2-(Prop-2-yn-1-yl)-2-(3,4,4-trimethyl-2λ^5^-penta-1,2-dien-1-yl)propane-1,3-diol (**1dx**) {#sec4.5.3}

^1^H NMR (400 MHz, CDCl~3~) δ = 5.01 (q, *J* = 2.9 Hz, 1H), 3.70 (s, 4H), 2.41 (d, *J* = 2.7 Hz, 2H), 2.17 (bs, 2H), 2.02 (t, *J* = 2.7 Hz, 1H), 1.71 (d, *J* = 2.9 Hz, 3H), 1.05 (s, 9H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 200.0, 111.6, 91.7, 81.2, 70.7, 67.5, 67.4, 44.3, 33.1, 29.0, 29.6, 22.8, 15.4; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~14~H~22~O~2~Na, 245.1512; found, 245.1521. Isolated yield: 97% (323 mg), as a semi-solid. Column chromatography (silica gel, pentane/ethyl acetate = 1:3).

Representative Procedure for the Synthesis of **1e**, **1f**, and **1g**: Synthesis of **1e** {#sec4.6}
---------------------------------------------------------------------------------------------

To a suspension of **1ax** (160 mg, 0.89 mmol) in THF (10 mL) was added NaH (60% in mineral oil (142 mg, 3.6 mmol)) at 0 °C. The reaction mixture was subsequently stirred for 30 min at the same temperature, and then MeI (0.45 mL, 7.1 mmol) was added. The reaction mixture was warmed to room temperature and stirred for 1 h. The reaction mixture was quenched by addition of water and extracted with Et~2~O (2 × 20 mL). The combined organic layers were washed with brine (20 mL) and dried (Na~2~SO~4~), and the solvent was removed under reduced pressure. The crude product was purified by flash column chromatography (silica gel, pentane/ethyl acetate = 98:2) to afford **1e** (150 mg, 81% yield) as a colorless oil.

In the same manner, **1f** and **1g** were obtained from **1cx** and **1dx**, respectively.

Characterization of Products **1e**, **1f**, and **1g** {#sec4.7}
-------------------------------------------------------

### 4,4-Bis(methoxymethyl)-7-methyl-6λ^5^-octa-5,6-dien-1-yne (**1e**) {#sec4.7.1}

^1^H NMR (400 MHz, CDCl~3~) δ = 5.00 (sept, *J* = 2.9 Hz, 1H), 3.36--3.31 (m, 10H), 2.32 (d, *J* = 2.5 Hz, 2H), 1.94 (t, *J* = 2.5 Hz, 1H), 1.68 (d, *J* = 2.7 Hz, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 201.5, 97.4, 90.7, 81.6, 75.4, 69.7, 59.3, 43.4, 23.4, 20.5; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~13~H~20~O~2~Na, 231.1356; found, 231.1367. Isolated yield: 81% (150 mg), as a colorless oil. Flash column chromatography (silica gel, pentane/ethyl acetate = 98:2).

### (3,3-Bis(methoxymethyl)-1λ^5^-hex-1-en-5-yn-1-ylidene)cyclohexane (**1f**) {#sec4.7.2}

^1^H NMR (400 MHz, CDCl~3~) δ = 5.00 (quint, *J* = 2.1 Hz, 1H), 3.34 (d, *J* = 2.9 Hz, 4H), 3.33 (s, 6H), 2.34 (d, *J* = 2.7 Hz, 2H), 2.19--2.05 (m, 4H), 1.94 (t, *J* = 2.7 Hz, 1H), 1.42--1.67 (m, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 198.0, 104.7, 90.5, 81.5, 75.5, 69.8, 59.4, 43.2, 31.5, 27.3, 26.1, 23.4; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~16~H~24~O~2~Na, 271.1669; found, 271.1670. Isolated yield: 95% (209 mg), as a colorless oil. Flash column chromatography (silica gel, pentane/ethyl acetate = 98:2).

### 4,4-Bis(methoxymethyl)-7,8,8-trimethyl-6λ^5^-nona-5,6-dien-1-yne (**1g**) {#sec4.7.3}

^1^H NMR (400 MHz, CDCl~3~) δ = 5.08 (q, *J* = 2.9 Hz, 1H), 3.36--3.29 (m, 10H), 2.32 (d, *J* = 2.6 Hz, 2H), 1.94 (t, *J* = 2.6 Hz, 1H), 1.68 (d, *J* = 2.7 Hz, 3H) 1.04 (s, 9H); ^113^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 199.7, 110.7, 92.5, 81.7, 75.5, 69.9, 59.3, 43.3, 33.1, 29.0, 23.3, 15.2; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~16~H~26~O~2~Na, 273.1825; found, 273.1829. Isolated yield: 85% (189 mg), as a colerless oil. Flash column chromatography (silica gel, pentane/ethyl acetate = 98:2).

Representative Procedure for the Synthesis of **1h** and **1i**: Synthesis of **1h** {#sec4.8}
------------------------------------------------------------------------------------

To a suspension of **1ax** (108 mg, 0.60 mmol) in acetone (5 mL) was added 2,2-dimethoxypropane (72 mg, 0.69 mmol) and *p*-TsOH·H~2~O (5.7 mg, 0.03 mmol). The reaction mixture was stirred at room temperature for 3 h and quenched with sat. NaHCO~3~ (aq.). Acetone was evaporated, and the residue was extracted with Et~2~O (2 × 20 mL). The combined organic layers were washed with brine (20 mL) and dried (Na~2~SO~4~), and the solvent was removed under reduced pressure. The crude product was purified by flash column chromatography (silica gel, pentane/ethyl acetate = 97:3) to yield **1h** (111 mg, 84% yield) as a colorless oil.

In the same manner, **1i** was obtained from **1dx**.

Characterization of Products **1h** and **1i** {#sec4.9}
----------------------------------------------

### 2,2-Dimethyl-5-(3-methyl-2λ^5^-buta-1,2-dien-1-yl)-5-(prop-2-yn-1-yl)-1,3-dioxane (**1h**) {#sec4.9.1}

^1^H NMR (400 MHz, CDCl~3~) δ = 4.88 (sept, *J* = 2.9 Hz, 1H), 3.70 (qt, *J* = 14.5 Hz, *J* = 11.6 Hz, 4H), 2.53 (d, *J* = 2.6 Hz, 2H), 1.99 (t, *J* = 2.7 Hz, 1H), 1.40 (d, *J* = 3.0 Hz, 6H), 1.39 (d, *J* = 8.1 Hz, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 201.7, 98.2, 97.9, 89.9, 81.4, 70.4, 66.9, 36.9, 27.6, 23.8, 20.5, 19.8; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~14~H~20~NaO~2~, 243.1356; found, 243.1364. Isolated yield: 84% (111 mg), as a colorless oil. Flash column chromatography (silica gel, pentane/ethyl acetate = 97:3).

### 2,2-Dimethyl-5-(prop-2-yn-1-yl)-5-(3,4,4-trimethyl-2λ^5^-penta-1,2-dien-1-yl)-1,3-dioxane (**1i**) {#sec4.9.2}

^1^H NMR (400 MHz, CDCl~3~) δ = 4.98 (q, *J* = 2.9 Hz, 1H), 3.77--3.61 (m, 4H), 2.54 (qd, *J* = 13.0 Hz, 2.6 Hz, 2H), 1.99 (t, *J* = 2.7 Hz, 1H), 1.70 (d, *J* = 3.0 Hz, 3H), 1.40 (d, *J* = 6.5 Hz, 6H), 1.04 (s, 9H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 199.9, 111.6, 97.9, 91.5, 81.5, 70.6, 66.9, 66.8, 36.8, 33.0, 29.0, 27.9, 24.0, 19.5, 15.3; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~17~H~26~O~2~Na, 285.1825; found, 285.1822. Isolated yield: 81% (128 mg), as a colorless oil. Flash column chromatography (silica gel, pentane/ethyl acetate = 97:3).

Synthesis and Characterization of **1j** {#sec4.10}
----------------------------------------

### (((2-(3-Methyl-2λ^5^-buta-1,2-dien-1-yl)-2-(prop-2-yn-1-yl)propane-1,3-diyl)bis(oxy))bis(methylene))dibenzene (**1j**) {#sec4.10.1}

To a suspension of NaH (60% in mineral oil, 124 mg, 3.1 mmol) in anhydrous DMF (3 mL) was added a solution of **1ax** (140 mg, 0.78 mmol) in anhydrous DMF (2 mL) at 0 °C. After the addition, the mixture was stirred for another 1 h at 0 °C. Then BnBr (170 μL, 1.4 mmol) was added at 0 °C, and the resulting mixture was stirred at rt overnight. Then the reaction mixture was diluted with 20 mL of Et~2~O and quenched with 5 mL of water. The organic layer was separated, and the aqueous layer was extracted with diethyl ether (2 × 20 mL). The combined organic layers were washed with H~2~O (10 mL) and dried (Na~2~SO~4~), and the solvent was removed under reduced pressure. The crude product was purified by column chromatography (silica gel, pentane/diethyl ether = 100:1) to yield **1j** (221 mg, 79% yield) as a liquid; ^1^H NMR (400 MHz, CDCl~3~): δ = 7.34--7.26 (m, 10H), 5.12 (sept, *J* = 2.9 Hz, 1H), 4.54 (s, 4H), 3.53 (s, 4H), 2.45 (d, *J* = 2.7 Hz, 2H), 1.95 (t, *J* = 2.7 Hz, 1H), 1.70 (d, *J* = 2.9 Hz, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ = 201.5, 138.7, 128.2, 127.3, 97.4, 90.9, 81.7, 73.3, 73.1, 69.8, 43.8, 23.5, 20.5; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~25~H~28~O~2~Na, 383.1982; found, 383.1987.

### Method A: Nonaerobic Oxidative Coupling-Carbocyclization for Preparation of **3** {#sec4.10.2}

#### Representative Procedure: Synthesis of **3a** {#sec4.10.2.1}

In a sealable microwave tube were placed **1a** (47.2 mg, 0.2 mmol), Pd(OAc)~2~ (2.2 mg, 0.01 mmol), 1,4-benzoquinone (BQ) (43.2 mg, 0.4 mmol), anhydrous Na~2~CO~3~ (4.2 mg, 0.04 mmol), and **2a** (77 mg, 0.4 mmol). To this mixture, 2.0 mL of anhydrous CH~3~CN solvent were added and the tube was sealed with the cap. The reaction was stirred at 80 °C in an oil bath for 24 h. After full consumption of starting material **1a** as monitored by TLC, the reaction mixture was concentrated in vacuo and purified via short column chromatography on silica gel (eluent: ethyl acetate/pentane, 5:95) affording 77 mg (90%) of **3a** as a liquid. The reaction was also run on a 1.3 mmol scale using **1a** (0.307 g, 1,3 mmol), which afforded 0.45g (81%) of **3a** after short column chromatography on silica gel (eluent: ethyl acetate/pentane, 5:95).

### Method B: Aerobic Oxidative Coupling-Carbocyclization for Preparation of **3** {#sec4.10.3}

#### Representative Procedure: Synthesis of **3a** {#sec4.10.3.1}

In a sealable microwave tube were placed **1a** (47.2 mg, 0.2 mmol), Pd(OAc)~2~ (2.2 mg, 0.01 mmol), Cobalt(salophen) (3.7 mg, 0.01 mmol), 20 mol % of 1,4-benzoquinone (BQ) (4.4 mg, 0.04 mmol), anhydrous Na~2~CO~3~(4.2 mg, 0.04 mmol) and **2a** (77 mg, 0.4 mmol). The tube was sealed with the cap. To this mixture was added 2.0 mL of anhydrous CH~3~CN via syringe. Then the reaction was stirred at 80 °C in an oil bath under an oxygen atmosphere using molecular oxygen balloon connected via a needle for 24 h. After full consumption of starting material **1a** as monitored by TLC, the reaction mixture was concentrated in vacuo and purified via short column chromatography on silica gel (eluent: ethyl acetate/pentane, 5:95) afforded 73 mg (85%) of **3a** as a liquid.

Characterization of Products **3** {#sec4.11}
----------------------------------

### Dimethyl-(Z)-4-((Z)-3-(2-ethoxy-2-oxoethyl)-2-(prop-1-en-2-yl)hexa-2,5-dien-1-ylidene)-3-(prop-1-en-2-yl)cyclopent-2-ene-1,1-dicarboxylate (**3a**) {#sec4.11.1}

^1^H NMR (400 MHz, CDCl~3~) δ = 6.24 (s, 1H), 5.94 (s, 1H), 5.76--5.66 (m, 1H), 5.15 (s, 1H), 5.10 (s, 1H), 5.06 (s, 1H), 5.02 (d, *J* = 4.9 Hz, 1H), 4.98 (s, 1H), 4.85 (d, *J* = 1.2 Hz, 1H), 4.09 (q, *J* = 7.1 Hz, 2H), 3.71 (s, 6H), 3.19 (d, *J* = 4.0 Hz, 4H), 2.93 (d, *J* = 6.4 Hz, 2H), 1.92 (s, 3H), 1.81 (s, 3H), 1.22 (t, *J* = 7.1 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 171.9, 170.9, 151.1, 144.2, 142.3, 139.9, 138.0, 135.0, 128.8, 119.5, 116.3, 116.0, 115.9, 63.8, 60.4, 52.7, 38.1, 36.9, 36.7, 23.2, 23.0, 14.1; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~25~H~32~O~6~Na, 451.2091; found, 451.2069. Isolated yield: Method A, 90% (77 mg); Method B, 85% (73 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 5:95).

### Diethyl-(Z)-4-((Z)-3-(2-ethoxy-2-oxoethyl)-2-(prop-1-en-2-yl)hexa-2,5-dien-1-ylidene)-3-(prop-1-en-2-yl)cyclopent-2-ene-1,1-dicarboxylate (**3b**) {#sec4.11.2}

^1^H NMR (400 MHz, CDCl~3~) δ = 6.24 (s, 1H), 5.95 (s, 1H), 5.76--5.66 (m, 1H), 5.15 (s, 1H), 5.10 (s, 1H), 5.06 (s, 1H), 5.02 (d, *J* = 6.6 Hz, 1H), 4.98 (s, 1H), 4.86 (s, 1H), 4.22--4.04 (m, 6H), 3.19 (s, 4H), 2.94 (d, *J* = 6.1 Hz, 2H), 1.93 (s, 3H), 1.82 (s, 3H), 1.23 (t, *J* = 7.1 Hz, 9H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 171.9, 170.5, 151.1, 144.3, 142.6, 140.0, 138.1, 135.0, 129.2, 128.7, 119.4, 116.1, 115.9, 115.8, 64.0, 61.5, 60.4, 38.2, 36.8, 36.7, 23.2, 23.1, 14.1, 13.9; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~27~H~36~O~6~Na, 479.2404; found, 479.2382. Isolated yield: Method A, 89% (82 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 5:95).

### Dimethyl-(Z)-3-(cyclohex-1-en-1-yl)-4-((Z)-3-(2-ethoxy-2-oxoethyl)-2-(prop-1-en-2-yl)hexa-2,5-dien-1-ylidene)cyclopent-2-ene-1,1-dicarboxylate (**3c**) {#sec4.11.3}

^1^H NMR (400 MHz, CDCl~3~) δ = 6.21 (s, 1H), 5.86 (s, 1H), 5.82--5.80 (m, 1H), 5.78--5.68 (m, 1H), 5.11--5.09 (m, 1H), 5.04--5.02 (m, 1H), 4.99 (s, 1H), 4.85 (d, *J* = 1.2 Hz, 1H), 4.09 (q, *J* = 7.1 Hz, 2H), 3.71 (s, 6H), 3.20 (s, 2H), 3.18 (d, *J* = 2.2 Hz, 2H), 2.94 (d, *J* = 6.4 Hz, 2H), 2.14--2.10 (m, 4H), 1.82 (s, 3H), 1.72--1.56 (m, 4H), 1.24 (t, *J* = 7.1 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 172.0, 171.2, 152.0, 144.2, 142.8, 140.2, 135.0, 131.4, 128.5, 128.1, 127.5, 119.2, 115.9, 115.8, 63.8, 60.4, 52.7, 38.2, 36.9, 36.8, 28.6, 25.3, 23.3, 22.7, 22.0, 14.1; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~28~H~36~O~6~Na, 491.2404; found, 491.2392. Isolated yield: Method A, 83% (77 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 5:95).

### Dimethyl-(Z)-3-(3,3-dimethylbut-1-en-2-yl)-4-((Z)-3-(2-ethoxy-2-oxoethyl)-2-(prop-1-en-2-yl)hexa-2,5-dien-1-ylidene)cyclopent-2-ene-1,1-dicarboxylate (**3d**) {#sec4.11.4}

^1^H NMR (400 MHz, CDCl~3~) δ = 6.07 (s, 1H), 5.80 (s, 1H), 5.76--5.63 (m, 1H), 5.25 (d, *J* = 1.4 Hz, 1H), 5.11 (s, 1H), 5.02--4.97 (m, 2H), 4.87--4.86 (m, 1H), 4.74 (d, *J* = 1.4 Hz, 1H), 4.09 (q, *J* = 7.1 Hz, 2H), 3.73 (s, 6H), 3.19 (s, 2H), 3.17 (d, *J* = 2.2 Hz, 2H), 2.91 (d, *J* = 6.4 Hz, 2H), 1.79 (s, 3H), 1.23 (t, *J* = 7.1 Hz, 3H), 1.06 (s, 9H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 172.0, 171.2, 152.0, 144.3, 142.8, 140.1, 135.0, 131.4, 128.5, 128.1, 127.5, 119.2, 115.9, 115.8, 63.8, 60.4, 52.7, 38.2, 36.9, 36.8, 28.7, 25.3, 23.3, 22.7, 22.0, 14.1; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~28~H~38~O~6~Na, 493.2561; found, 493.2573. Isolated yield: Method A, 82% (78 mg); Method B, 78% (74 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 5:95).

### Ethyl-(Z)-3-allyl-4-((Z)-(4,4-bis(methoxymethyl)-2-(prop-1-en-2-yl)cyclopent-2-en-1-ylidene)methyl)-5-methylhexa-3,5-dienoate (**3e**) {#sec4.11.5}

^1^H NMR (400 MHz, CDCl~3~) δ = 6.18 (s, 1H), 5.85 (s, 1H), 5.78--5.66 (m, 1H), 5.09 (s, 1H), 5.05--4.98 (m, 4H), 4.82 (s, 1H), 4.11 (q, *J* = 7.1 Hz, 2H), 3.31 (s, 6H), 3.26 (s, 4H), 3.19 (s, 2H), 2.94 (d, *J* = 6.4 Hz, 2H), 2.43 (d, *J* = 2.1 Hz, 2H), 1.91 (s, 3H), 1.79 (s, 3H), 1.24 (t, *J* = 7.1 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 172.2, 148.8, 145.0, 144.6, 140.6, 138.9, 136.1, 135.3, 127.2, 118.1, 115.8, 115.3, 115.0, 60.3, 59.3, 52.2, 38.0, 36.9, 36.4, 23.3, 23.2, 14.1; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~25~H~36~O~4~Na, 423.2506; found, 423.2494. Isolated yield: Method A, 80% (64 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 4:96).

### Ethyl-(Z)-3-allyl-4-((Z)-(2-(cyclohex-1-en-1-yl)-4,4-bis(methoxymethyl)cyclopent-2-en-1-ylidene)methyl)-5-methylhexa-3,5-dienoate (**3f**) {#sec4.11.6}

^1^H NMR (400 MHz, CDCl~3~) δ = 6.14 (s, 1H), 5.83--5.68 (m, 3H), 5.06--4.98 (m, 3H), 4.81 (dd, *J* = 2.4 Hz, 0.9 Hz, 1H), 4.10 (q, *J* = 7.1 Hz, 2H), 3.31 (s, 6H), 3.26 (s, 4H), 3.19 (s, 2H), 2.94 (d, *J* = 6.4 Hz, 2H), 2.40 (d, *J* = 2.1 Hz, 2H), 2.16--2.07 (m, 4H), 1.79 (s, 3H), 1.71--1.57 (m, 4H), 1.24 (t, *J* = 7.1 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 172.2, 149.8, 145.5, 144.7, 140.8, 135.3, 134.5, 132.1, 126.9, 126.9, 117.7, 115.8, 115.2, 60.3, 59.3, 52.1, 38.1, 36.9, 36.4, 28.7, 25.3, 23.2, 22.9, 22.2, 14.1; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~28~H~40~O~4~Na: 463.2819; found, 463.2825. Isolated yield: Method A, 77% (68 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 5:95).

### Ethyl-(Z)-3-allyl-4-((Z)-(2-(3,3-dimethylbut-1-en-2-yl)-4,4-bis(methoxymethyl)cyclopent-2-en-1-ylidene)methyl)-5-methylhexa-3,5-dienoate (**3g**) {#sec4.11.7}

^1^H NMR (400 MHz, CDCl~3~) δ = 5.97 (s, 1H), 5.76--5.68 (m, 1H), 5.66 (s, 1H), 5.20 (d, *J* = 1.7 Hz, 1H), 5.07--4.97 (m, 3H), 4.82 (dd, *J* = 2.4 Hz, 0.9 Hz, 1H), 4.69 (d, *J* = 1.7 Hz, 1H), 4.11 (q, *J* = 7.1 Hz, 2H), 3.32 (s, 6H), 3.28 (s, 4H), 3.18 (s, 2H), 2.91 (d, *J* = 6.4 Hz, 2H), 2.39 (d, *J* = 2.3 Hz, 2H), 1.76 (s, 3H), 1.24 (t, *J* = 7.1 Hz, 3H), 1.06 (s, 9H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 172.3, 152.7, 148.7, 148.5, 144.4, 140.7, 136.5, 135.2, 127.1, 117.8, 115.6, 115.5, 112.2, 60.3, 59.3, 52.8, 38.1, 36.8, 35.8, 35.2, 29.5, 23.3, 14.1; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~28~H~42~O~4~Na, 465.2975; found, 465.2985. Isolated yield: Method A, 81% (71 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 4:96).

### Ethyl-(Z)-3-allyl-4-((Z)-(8,8-dimethyl-3-(prop-1-en-2-yl)-7,9-dioxaspiro\[4.5\]dec-3-en-2-ylidene)methyl)-5-methylhexa-3,5-dienoate (**3h**) {#sec4.11.8}

^1^H NMR (400 MHz, CDCl~3~) δ = 6.21 (s, 1H), 5.96 (s, 1H), 5.77--5.66 (m, 1H), 5.11 (s, 1H), 5.07 (s, 1H), 5.04--4.99 (m, 3H), 4.84 (d, *J* = 1.3 Hz, 1H), 4.11 (q, *J* = 7.1 Hz, 2H), 3.69 (d, *J* = 11.3 Hz, 2H), 3.59 (d, *J* = 11.3 Hz, 2H), 3.20 (s, 2H), 2.93 (d, *J* = 6.4 Hz, 2H), 2.49 (d, *J* = 2.2 Hz, 2H), 1.92 (s, 3H), 1.79 (s, 3H), 1.43 (d, *J* = 5.8 Hz, 6H), 1.24 (t, *J* = 7.1 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 172.1, 149.1, 144.5, 144.1, 140.4, 138.8, 135.2, 135.1, 127.8, 118.6, 115.9, 115.6, 115.2, 97.5, 68.4, 60.4, 46.5, 38.1, 37.5, 36.8, 24.0, 23.5, 23.3, 23.3, 14.1; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~26~H~36~O~4~Na, 435.2506; found, 435.2497. Isolated yield: Method A, 75% (62 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 5:95).

### Ethyl-(Z)-3-allyl-4-((Z)-(3-(3,3-dimethylbut-1-en-2-yl)-8,8-dimethyl-7,9-dioxaspiro\[4.5\]dec-3-en-2-ylidene)methyl)-5-methylhexa-3,5-dienoate (**3i**) {#sec4.11.9}

^1^H NMR (400 MHz, CDCl~3~) δ = 6.00 (s, 1H), 5.77 (s, 1H), 5.77--5.66 (m, 1H), 5.21 (s, 1H), 5.09 (s, 1H), 5.02 (d, *J* = 6.8 Hz, 1H), 4.97 (s, 1H), 4.85 (s, 1H), 4.69 (d, *J* = 1.5 Hz, 1H), 4.11 (q, *J* = 7.1 Hz, 2H), 3.72 (d, *J* = 11.3 Hz, 2H), 3.60 (d, *J* = 11.3 Hz, 2H), 3.19 (s, 2H), 2.91 (d, *J* = 6.4 Hz, 2H), 2.48 (d, *J* = 2.2 Hz, 2H), 1.77 (s, 3H), 1.43 (d, *J* = 4.3 Hz, 6H), 1.25 (t, *J* = 7.1 Hz, 3H), 1.06 (s, 9H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 172.3, 152.5, 149.1, 147.4, 144.4, 140.5, 135.5, 135.0, 127.7, 118.7, 115.8, 115.7, 112.5, 97.5, 68.6, 60.4, 47.1, 38.2, 36.8, 36.6, 35.7, 29.6, 24.3, 23.4, 23.3, 14.2;; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~29~H~42~O~4~Na, 477.2975; found, 477.2977. Isolated yield: Method A, 34% (31 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 5:95).

### Ethyl(Z)-3-allyl-4-((Z)-(4,4-bis((benzyloxy)methyl)-2-(prop-1-en-2-yl)cyclopent-2-en-1-ylidene)methyl)-5-methylhexa-3,5-dienoate (**3j**) {#sec4.11.10}

^1^H NMR (400 MHz, CDCl~3~) δ = 7.34--7.23 (m, 10H), 6.19 (s, 1H), 5.93 (s, 1H), 5.80--5.68 (m, 1H), 5.11--4.99 (m, 5H), 4.84 (s, 1H), 4.51 (s, 4H), 4.10 (q, *J* = 7.1 Hz, 2H), 3.43 (s, 4H), 3.21 (s, 2H), 2.95 (d, *J* = 6.4 Hz, 2H), 2.50 (d, *J* = 2.1 Hz, 2H), 1.93 (s, 3H), 1.79 (s, 3H), 1.24 (t, *J* = 7.1 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 172.2, 148.9, 145.2, 144.7, 140.7, 139.0, 138.8, 136.4, 135.3, 128.2, 127.3, 127.3, 127.2, 117.9, 115.8, 115.3, 115.0, 73.5, 73.2, 60.4, 52.4, 38.0, 36.9, 36.6, 23.4, 23.3, 14.1; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~37~H~44~O~4~Na, 575.3132; found, 575.3125. Isolated yield: Method A, 83% (91 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 3:97).

### Dimethyl-(Z)-4-((Z)-3-(ethoxycarbonyl)-2-(prop-1-en-2-yl)hexa-2,5-dien-1-ylidene)-3-(prop-1-en-2-yl)cyclopent-2-ene-1,1-dicarboxylate (**3k**) {#sec4.11.11}

^1^H NMR (400 MHz, CDCl~3~) δ = 6.19 (t, *J* = 2.2 Hz, 1H), 6.03 (s, 1H), 5.82--5.72 (m, 1H), 5.19 (s, 1H), 5.07--4.99 (m, 3H), 4.95 (s, 1H), 4.87 (d, *J* = 0.8 Hz, 1H), 4.11 (q, *J* = 7.1 Hz, 2H), 3.73 (s, 6H), 3.22 (d, *J* = 2.2 Hz, 2H), 3.07 (d, *J* = 6.1 Hz, 2H), 1.93 (d, *J* = 4.0 Hz, 6H), 1.23 (t, *J* = 7.1 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 172.7, 169.9, 150.9, 145.8, 145.6, 144.7, 137.6, 134.2, 130.5, 129.8, 118.3, 116.6, 116.0, 115.2, 63.9, 60.3, 52.9, 37.0, 34.4, 23.0, 22.7, 13.8; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~24~H~30~O~6~Na, 437.1940; found, 437.1950. Isolated yield: Method A, 85% (70 mg); Method B, 87% (72 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 5:95).

### Dimethyl-(Z)-4-((Z)-3-(2-ethoxy-2-oxoethyl)-2-(prop-1-en-2-yl-d5)hexa-2,5-dien-1-ylidene)-3-(prop-1-en-2-yl)cyclopent-2-ene-1,1-dicarboxylate (**3l**) {#sec4.11.12}

^1^H NMR (400 MHz, CDCl~3~) δ = 6.26 (s, 1H), 5.95 (s, 1H), 5.73--5.69 (m, 1H), 5.16 (s, 1H), 5.07--4.99 (m, 3H), 4.11 (q, *J* = 7.0 Hz, 2H), 3.72 (s, 6H), 3.20 (s, 4H), 2.95 (d, *J* = 5.7 Hz, 2H), 1.94 (s, 3H), 1.24 (t, *J* = 7.1 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 172.0, 171.0, 151.2, 144.0, 142.3, 139.9, 138.0, 135.0, 128.9, 128.8, 119.6, 116.3, 116.0, 63.9, 60.4, 52.8, 38.2, 36.9, 36.8, 23.1, 14.1; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~25~H~27~D~5~O~6~Na, 456.2410; found, 456.2393. Isolated yield: Method A, 72% (62 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 5:95).

### Dimethyl-(Z)-4-((Z)-2-(cyclohex-1-en-1-yl)-3-(2-ethoxy-2-oxoethyl)hexa-2,5-dien-1-ylidene)-3-(prop-1-en-2-yl)cyclopent-2-ene-1,1-dicarboxylate (**3m**) {#sec4.11.13}

^1^H NMR (400 MHz, CDCl~3~) δ = 6.27 (t, *J* = 2.2 Hz, 1H), 5.92 (s, 1H), 5.77--5.67 (m, 1H), 5.55 (sept, *J* = 2.2 Hz, 1H), 5.16--5.15 (m, 1H), 5.06--4.98 (m, 3H), 4.11 (q, *J* = 7.1 Hz, 2H), 3.73 (s, 6H), 3.22 (d, *J* = 2.2 Hz, 2H), 3.17 (s, 2H), 2.94 (d, *J* = 6.1 Hz, 2H), 2.11--2.09 (m, 2H), 1.98--1.93 (m, 5H), 1.60--1.70 (m, 4H), 1.23 (t, *J* = 7.1 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 172.2, 171.1, 151.4, 141.9, 140.5, 138.1, 137.1, 135.2, 129.1, 128.5, 126.9, 120.1, 116.2, 115.8, 63.9, 60.4, 52.8, 38.3, 37.0, 36.8, 28.9, 25.3, 23.1, 22.7, 21.9, 14.1; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~28~H~36~O~6~Na, 491.2404; found, 491.2421. Isolated yield: Method A, 78% (74 mg); Method B, 80% (76 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 5:95).

### Dimethyl-(Z)-4-((Z)-2-(cyclopent-1-en-1-yl)-3-(2-ethoxy-2-oxoethyl)hexa-2,5-dien-1-ylidene)-3-(prop-1-en-2-yl)cyclopent-2-ene-1,1-dicarboxylate (**3n**) {#sec4.11.14}

^1^H NMR (400 MHz, CDCl~3~) δ = 6.27 (s, 1H), 5.93 (s, 1H), 5.77--5.67 (m, 1H), 5.58 (s, 1H), 5.15 (s, 1H), 5.07 (s, 1H), 5.03--4.98 (m, 2H), 4.11 (q, *J* = 7.1 Hz, 2H), 3.72 (s, 6H), 3.17 (s, 2H), 3.09 (d, *J* = 2.2 Hz, 2H), 2.94 (d, *J* = 6.1 Hz, 2H), 2.36 (dt, *J* = 40.2 Hz, 7.1 Hz, 4H), 1.94--1.88 (m, 5H), 1.24 (t, *J* = 7.1 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 172.0, 171.0, 150.8, 142.3, 142.1, 137.9, 135.2, 135.0, 130.0, 129.4, 128.7, 120.2, 116.2, 116.0, 63.7, 60.4, 52.8, 38.3, 37.2, 36.7, 36.2, 32.9, 23.4, 23.0, 14.1; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~27~H~34~O~6~Na, 477.2248; found, 477.2249. Isolated yield: Method A, 75% (69 mg); Method B, 77% (71 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 5:95).

### Dimethyl-(Z)-4-((Z)-3-(2-ethoxy-2-oxoethyl)-2-vinylhexa-2,5-dien-1-ylidene)-3-(prop-1-en-2-yl)cyclopent-2-ene-1,1-dicarboxylate (**3o**) {#sec4.11.15}

^1^H NMR (400 MHz, CDCl~3~) δ = 6.64 (dd, *J* = 17.1 Hz, 10.5 Hz, 1H), 6.13 (s, 1H), 6.02 (s, 1H), 5.74--5.63 (m, 1H), 5.20--5.13 (m, 4H), 5.03 (d, *J* = 6.1 Hz, 1H), 5.00 (s, 1H), 4.13 (q, *J* = 7.1 Hz, 2H), 3.71 (s, 6H), 3.25 (s, 2H), 2.98--2.96 (m, 4H), 1.98 (s, 3H), 1.25 (t, *J* = 7.1 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 171.2, 170.9, 149.1, 144.0, 137.6, 135.2, 134.9, 132.3, 130.4, 129.6, 119.3, 116.8, 116.6, 116.4, 63.3, 60.7, 52.8, 39.3, 37.1, 36.5, 22.9, 14.1; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~24~H~30~O~6~Na, 437.1940; found, 437.1931. Isolated yield: Method A, 61% (50 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 5:95).

### Dimethyl-(Z)-4-((2Z,5E)-3-(ethoxycarbonyl)-2-(prop-1-en-2-yl)octa-2,5-dien-1-ylidene)-3-(prop-1-en-2-yl)cyclopent-2-ene-1,1-dicarboxylate (**3p**) {#sec4.11.16}

^1^H NMR (400 MHz, CDCl~3~) δ = 6.21 (t, *J* = 7.1 Hz, 2H), 6.03 (s, 1H), 5.52--5.45 (m, 1H), 5.37--5.30 (m, 1H), 5.19 (pent, *J* = 1.4 Hz, 1H), 5.07 (s, 1H), 4.95 (pent, *J* = 1.6 Hz, 1H), 4.87 (dd, *J* = 1.0 Hz, 1.9 Hz, 1H), 4.11 (q, *J* = 7.1 Hz, 2H), 3.73 (s, 6H), 3.22 (d, *J* = 2.2 Hz, 2H), 3.01 (d, *J* = 6.1 Hz, 2H), 1.95--1.93 (m, 8H), 1.23 (t, *J* = 7.1 Hz, 3H), 0.93 (t, *J* = 7.4 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 170.7, 170.1, 151.0, 145.7, 145.5, 143.7, 137.7, 134.0, 130.9, 130.3, 124.4, 118.5, 116.6, 115.2, 64.0, 60.3, 52.9, 37.0, 33.4, 25.5, 23.0, 22.7, 13.9, 13.7; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~26~H~34~O~6~Na, 465.2248; found, 465.2239. Isolated yield: Method A, 76% (67 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 7:93).

### Dimethyl-(Z)-4-((2Z,5E)-3-(ethoxycarbonyl)-6-phenyl-2-(prop-1-en-2-yl)hexa-2,5-dien-1-ylidene)-3-(prop-1-en-2-yl)cyclopent-2-ene-1,1-dicarboxylate (**3q**) {#sec4.11.17}

^1^H NMR (400 MHz, CDCl~3~) δ = 7.33--7.18 (m, 5H), 6.40 (d, *J* = 15.8 Hz, 1H), 6.27 (s, 1H), 6.18--6.10 (m, 1H), 6.05 (s, 1H), 5.22--5.20 (m, 1H), 5.09 (s, 1H), 4.97 (s, 1H), 4.90 (s, 1H), 4.13 (q, *J* = 7.1 Hz, 2H), 3.72 (s, 6H), 3.26--3.23 (m, 4H), 1.96 (s, 6H), 1.24 (t, *J* = 7.1 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 170.7, 169.9, 150.9, 146.0, 145.6, 144.9, 137.7, 137.4, 131.3, 130.6, 129.8, 128.4, 127.0, 126.2, 126.1, 118.4, 116.7, 115.2, 64.0, 60.4, 52.9, 37.1, 33.8, 23.1, 22.7, 13.8; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~30~H~34~O~6~Na, 513.2253; found, 513.2260. Isolated yield: Method A, 57% (56 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 5:95).

### Dimethyl-(Z)-4-((Z)-3-(ethoxycarbonyl)-6-methyl-2-(prop-1-en-2-yl)hepta-2,5-dien-1-ylidene)-3-(prop-1-en-2-yl)cyclopent-2-ene-1,1-dicarboxylate (**3r**) {#sec4.11.18}

^1^H NMR (400 MHz, CDCl~3~) δ = 6.20 (t, *J* = 2.2 Hz, 1H), 6.02 (s, 1H), 5.19--5.17 (m, 1H), 5.07--5.04 (m, 2H), 4.93 (s, 1H), 4.86 (s, 1H), 4.10 (q, *J* = 7.1 Hz, 2H), 3.73 (s, 6H), 3.21 (d, *J* = 2.2 Hz, 2H), 3.01 (d, *J* = 6.9 Hz, 2H), 1.92 (d, *J* = 12.5 Hz, 6H), 1.66 (s, 3H), 1.60 (s, 3H), 1.23 (t, *J* = 7.1 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 170.7, 170.2, 150.9, 145.7, 145.3, 142.9, 137.7, 133.1, 131.6, 130.2, 120.2, 118.5, 116.6, 115.2, 63.9, 60.2, 52.9, 37.0, 29.4, 25.6, 23.0, 22.6, 17.8, 13.8; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~26~H~34~O~6~Na, 465.2253; found, 465.2238. Isolated yield: Method A, 71% (63 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 5:95).

### Dimethyl-(Z)-4-((Z)-3-(2-ethoxy-2-oxoethyl)-5-methyl-2-(prop-1-en-2-yl)hexa-2,5-dien-1-ylidene)-3-(prop-1-en-2-yl)cyclopent-2-ene-1,1-dicarboxylate (**3s**) {#sec4.11.19}

^1^H NMR (400 MHz, CDCl~3~) δ = 6.26 (s, 1H), 5.94 (s, 1H), 5.16--5.12 (m, 2H), 5.06 (s, 1H), 4.87 (s, 1H), 4.76 (s, 1H), 4.66 (s, 1H), 4.10 (q, *J* = 7.1 Hz, 2H), 3.72 (s, 6H), 3.21 (d, *J* = 2.1 Hz, 2H), 3.19 (s, 2H), 2.90 (s, 2H), 1.93 (s, 3H), 1.84 (s, 3H), 1.65 (s, 3H), 1.24 (t, *J* = 7.1 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 172.0, 171.0, 151.2, 144.4, 142.7, 142.2, 140.6, 138.0, 129.0, 128.7, 119.8, 116.2, 115.9, 111.7, 63.9, 60.4, 52.8, 40.4, 38.0, 36.9, 23.3, 23.1, 22.3, 14.1; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~26~H~34~O~6~Na, 465.2248; found, 465.2240. Isolated yield: Method A, 80% (71 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 5:95).

### Dimethyl-(Z)-4-((E)-3-allyl-2-(prop-1-en-2-yl)hept-2-en-1-ylidene)-3-(prop-1-en-2-yl)cyclopent-2-ene-1,1-dicarboxylate (**3t**) {#sec4.11.20}

^1^H NMR (400 MHz, CDCl~3~) δ = 6.26 (s, 1H), 5.89 (s, 1H), 5.77--5.67 (m, 1H), 5.15 (s, 1H), 5.08 (s, 1H), 5.06 (s, 1H), 5.03--4.96 (m, 2H), 4.80 (s, 1H), 3.72 (s, 6H), 3.21 (d, *J* = 2.1 Hz, 2H), 2.86 (d, *J* = 6.1 Hz, 2H), 2.13--2.09 (m, 2H), 1.93 (s, 3H), 1.84 (s, 3H), 1.36--1.27 (m, 5H), 0.88 (t, *J* = 7.1 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 171.2, 151.7, 144.7, 140.3, 138.2, 137.5, 136.5, 136.1, 127.7, 120.5, 116.2, 115.1, 63.9, 52.8, 36.9, 36.0, 32.9, 31.5, 23.9, 23.2, 23.0, 13.9; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~25~H~34~O~4~Na, 421.2349; found, 421.2353. Isolated yield: Method A, 80% (64 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 3:97).

### Dimethyl-(Z)-4-((Z)-3-phenyl-2-(prop-1-en-2-yl)hexa-2,5-dien-1-ylidene)-3-(prop-1-en-2-yl)cyclopent-2-ene-1,1-dicarboxylate (**3u**) {#sec4.11.21}

^1^H NMR (400 MHz, CDCl~3~) δ = 7.27--7.15 (m, 10H), 6.42 (t, *J* = 2.2 Hz, 1H), 5.98 (s, 1H), 5.91 (t, *J* = 2.2 Hz, 1H), 5.83 (s, 1H), 5.74--5.65 (m, 2H), 5.21 (s, 2H), 5.15 (s, 2H), 4.90--4.85 (m, 6H), 4.73 (s, 1H), 4.70 (s, 1H), 3.73 (d, *J* = 4.8 Hz, 12H), 3.27--3.20 (m, 8H), 1.98 (d, *J* = 14.8 Hz, 6H), 1.65 (d, *J* = 17.4 Hz, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 171.1, 171.0, 152.0, 151.2, 144.4, 143.9, 143.1, 142.5, 141.6, 140.3, 139.0, 138.4, 138.0, 137.8, 137.5, 136.7, 135.0, 129.4, 128.7, 128.6, 127.8, 127.6, 127.5, 126.6, 126.3, 121.9, 121.2, 117.9, 116.3, 116.0, 115.9, 115.5, 115.4, 63.9, 63.9, 52.8, 52.8, 39.7, 39.4, 37.1, 36.8, 23.8, 23.5, 23.1, 22.8; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~27~H~30~O~4~Na, 441.2036; found, 441.2034. Isolated yield: Method A, 60% (50 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 3:97).

### Dimethy-(Z)-4-((Z)-3-(2-hydroxyethyl)-2-(prop-1-en-2-yl)hexa-2,5-dien-1-ylidene)-3-(prop-1-en-2-yl)cyclopent-2-ene-1,1-dicarboxylate (**3v**) {#sec4.11.22}

^1^H NMR (400 MHz, CDCl~3~) δ = 6.27 (s, 1H), 5.93 (s, 1H), 5.81--5.71 (m, 1H), 5.17 (s, 1H), 5.13 (s, 1H), 5.06--5.01 (m, 3H), 4.84 (s, 1H), 4.45 (s, 1H), 3.73 (s, 6H), 3.67 (q, *J* = 7.1 Hz, 2H), 3.22 (d, *J* = 2.1 Hz, 2H), 2.91 (d, *J* = 6.1 Hz, 2H), 2.46 (t, *J* = 7.1 Hz, 2H), 1.94 (s, 3H), 1.86 (s, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~) δ = 171.1, 151.6, 149.4, 144.5, 141.3, 139.4, 138.1, 135.8, 132.6, 128.4, 119.9, 116.3, 116.1, 115.8, 115.6, 63.9, 61.8, 52.9, 36.9, 36.6, 36.2, 24.0, 23.2; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~23~H~30~O~5~Na, 409.1985; found, 409.1986. Isolated yield: Method A, 63% (49 mg), as a liquid. Column chromatography on silica gel (eluent: ethyl acetate/pentane, 10:90).

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acs.joc.0c00186](https://pubs.acs.org/doi/10.1021/acs.joc.0c00186?goto=supporting-info).General preparation of starting materials, mechanistic study, kinetic isotope effect (KIE) experiments, and ^1^H/^13^C NMR spectra ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acs.joc.0c00186/suppl_file/jo0c00186_si_001.pdf))
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